Out of 19.9 million insured people, 16.7m are treated

Out of 19.9 million insured people in our database, an astonishing 16.7 million are patients receiving medical products. This highlights the immense demand for pharmaceuticals in Europe’s largest healthcare market.

For U.S. pharmaceutical companies, this represents a unique opportunity to tap into a highly active market with substantial patient access. With Germany leading in healthcare infrastructure and prescription volume, it’s the ideal entry point for innovative therapies aiming to reach the European market.

At patientsbridge, we help you capitalize on this demand by:

• Streamlining Market Entry: Navigate Germany’s healthcare system with ease.

• Regulatory Expertise: Align with AMNOG and EU HTA frameworks for faster access.

• Patient-Centric Insights: Leverage data to position your therapies for maximum impact.

Germany’s 19.9 million insured patients aren’t just numbers—they’re an opportunity to grow your business in Europe. Let patientsbridge guide you there.